338 related articles for article (PubMed ID: 19759927)
1. A categorization of metal anticancer compounds based on their mode of action.
Gianferrara T; Bratsos I; Alessio E
Dalton Trans; 2009 Oct; (37):7588-98. PubMed ID: 19759927
[TBL] [Abstract][Full Text] [Related]
2. Metal based drugs: from serendipity to design.
Fricker SP
Dalton Trans; 2007 Nov; (43):4903-17. PubMed ID: 17992275
[TBL] [Abstract][Full Text] [Related]
3. Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.
Peacock AF; Sadler PJ
Chem Asian J; 2008 Nov; 3(11):1890-9. PubMed ID: 18712745
[TBL] [Abstract][Full Text] [Related]
4. New trends for metal complexes with anticancer activity.
Bruijnincx PC; Sadler PJ
Curr Opin Chem Biol; 2008 Apr; 12(2):197-206. PubMed ID: 18155674
[TBL] [Abstract][Full Text] [Related]
5. Anticancer metal compounds in NCI's tumor-screening database: putative mode of action.
Huang R; Wallqvist A; Covell DG
Biochem Pharmacol; 2005 Apr; 69(7):1009-39. PubMed ID: 15763539
[TBL] [Abstract][Full Text] [Related]
6. Metal-based antitumour drugs in the post-genomic era: what comes next?
Sava G; Bergamo A; Dyson PJ
Dalton Trans; 2011 Sep; 40(36):9069-75. PubMed ID: 21725573
[TBL] [Abstract][Full Text] [Related]
7. Fast and slow versus strong and weak metal-DNA binding: consequences for anti-cancer activity.
Reedijk J
Metallomics; 2012 Jul; 4(7):628-32. PubMed ID: 22488113
[TBL] [Abstract][Full Text] [Related]
8. Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNA.
Chifotides HT; Dunbar KR
Acc Chem Res; 2005 Feb; 38(2):146-56. PubMed ID: 15709734
[TBL] [Abstract][Full Text] [Related]
9. Exploring biologically relevant chemical space with metal complexes.
Meggers E
Curr Opin Chem Biol; 2007 Jun; 11(3):287-92. PubMed ID: 17548234
[TBL] [Abstract][Full Text] [Related]
10. Metal-based antitumour drugs in the post genomic era.
Dyson PJ; Sava G
Dalton Trans; 2006 Apr; (16):1929-33. PubMed ID: 16609762
[TBL] [Abstract][Full Text] [Related]
11. New directions in supramolecular transition metal catalysis.
Wilkinson MJ; van Leeuwen PW; Reek JN
Org Biomol Chem; 2005 Jul; 3(13):2371-83. PubMed ID: 15976851
[TBL] [Abstract][Full Text] [Related]
12. DNA structural distortions induced by ruthenium-arene anticancer compounds.
Gossens C; Tavernelli I; Rothlisberger U
J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736
[TBL] [Abstract][Full Text] [Related]
13. Design of targeting ligands in medicinal inorganic chemistry.
Storr T; Thompson KH; Orvig C
Chem Soc Rev; 2006 Jun; 35(6):534-44. PubMed ID: 16729147
[TBL] [Abstract][Full Text] [Related]
14. Recent insights on the medicinal chemistry of metal-based compounds: hints for the successful drug design.
Hernandes MZ; de S Pontes FJ; Coelho LC; Moreira DR; Pereira VR; Leite AC
Curr Med Chem; 2010; 17(31):3739-50. PubMed ID: 20846108
[TBL] [Abstract][Full Text] [Related]
15. Design of anticancer prodrugs for reductive activation.
Chen Y; Hu L
Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784
[TBL] [Abstract][Full Text] [Related]
16. Metal ionophores - an emerging class of anticancer drugs.
Ding WQ; Lind SE
IUBMB Life; 2009 Nov; 61(11):1013-8. PubMed ID: 19859983
[TBL] [Abstract][Full Text] [Related]
17. On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imaging.
Karaca Ö; Meier-Menches SM; Casini A; Kühn FE
Chem Commun (Camb); 2017 Jul; 53(59):8249-8260. PubMed ID: 28653066
[TBL] [Abstract][Full Text] [Related]
18. Recent researches in metal supramolecular complexes as anticancer agents.
Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
[TBL] [Abstract][Full Text] [Related]
19. Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies.
Casini A; Guerri A; Gabbiani C; Messori L
J Inorg Biochem; 2008; 102(5-6):995-1006. PubMed ID: 18289690
[TBL] [Abstract][Full Text] [Related]
20. Interactions of metal ions with DNA, its constituents and derivatives, which may be relevant for anticancer research.
Turel I; Kljun J
Curr Top Med Chem; 2011; 11(21):2661-87. PubMed ID: 22039873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
